Development of proliferative retinopathy in a gestational diabetes patient following rapid metabolic control.
Rapid glucose control was achieved by insulin therapy in a patient diagnosed to have gestational diabetes at 8 weeks of pregnancy. A decrease of the initially high hemoglobin A1c level (16.2%) to normal values (5.9%) was achieved within 12 weeks. At 31 weeks severe bilateral proliferative diabetic retinopathy developed. To our knowledge this case is the first report of a patient with gestational diabetes who developed de novo proliferative diabetic retinopathy.
Hagay
Z J
ZJ
Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel.
Schachter
M
M
Pollack
A
A
Levy
R
R
D000328:Adult; D016640:Diabetes, Gestational / Q000378:metabolism / Q000517:prevention & control*; D003930:Diabetic Retinopathy / Q000209:etiology*; D005260:Female; D006441:Hemoglobin A / Q000378:metabolism*; D006801:Humans; D007328:Insulin / Q000008:administration & dosage; D011247:Pregnancy
D007328:Insulin; D006441:Hemoglobin A